ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 52

In Vivo Effect of Opticin Deficiency in a Surgically Induced Mouse Model of Osteoarthritis

Aina Farran1, Gladys Valverde-Franco2, Laura Tio3, Bertrand Lussier4, Hassan Fahmi2, Jean-Pierre Pelletier2, Paul Bishop5, Jordi Monfort6 and Johanne Martel-Pelletier2, 1Osteoarthritis Research Unit (CRCHUM), Montreal; Inflammation and Cartilage Cellular Research Group, IMIM (Hospital del Mar Research Unit) Rheumatology Department, Parc de Salut Mar, Hospital del Mar, Barcelona, Barcelona, Spain, 2Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 3Inflammation and Cartilage Cellular Research Group, IMIM (Hospital del Mar Research Unit) Rheumatology Department, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain, 4Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM); Faculty of Veterinary Medicine, Clinical Sciences, University of Montreal, Sainte-Hyacinthe, QC, Canada, 5Manchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre; School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, 6Inflammation and Cartilage Cellular Research Group, IMIM (Hospital del Mar Research Unit) Rheumatology Department, Parc de Salut Mar; Rheumatology Department, Hospital del Mar, Barcelona, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: mouse model and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Biology and Pathology of Bone and Joint Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Opticin (OPTC) is a small leucine-rich proteoglycan (SLRP) that has been previously demonstrated to be produced and degraded in osteoarthritic (OA) human cartilage. Here, we further investigated the in vivo effect of OPTC deficiency in OA cartilage.

Methods: OA was induced in 10-week-old Optc-/- (knock-out) and Optc+/+ (wild type) mice by destabilization of the medial meniscus (DMM). Ten weeks post-surgery, cartilage was processed for histology, and immunohistochemistry. SLRP expression was determined in non-operated mouse cartilage at day 3 (P03) and 10 weeks of age. Collagen ultrastructure was analyzed by transmission electron microscopy in 10-week-old non-operated mouse cartilage.

Results: OA Optc-/- mice demonstrated significant protection against cartilage degradation. Data revealed that in non-operated Optc-/- mouse cartilage, the SLRPs lumican and epiphycan were significantly up-regulated at P03 (p≤0.010) and 10 weeks old (p≤0.007), and fibromodulin down-regulated at 10 weeks of age (p≤0.001). Immunohistochemistry of OA mice showed a similar pattern. In OA Optc-/- mouse cartilage, markers of cartilage degradation and complement factors C5b-9 and CCL2 were all down-regulated (p≤0.050). In Optc-/- mouse cartilage, collagen fibers were thinner and better organized (p=0.038) than in OA Optc+/+ mouse cartilage.

Conclusion: This work demonstrates a protective effect of OPTC deficiency during OA, resulting from an overexpression of lumican and epiphycan, known to bind and protect collagen fibers, and a decrease in fibromodulin, contributing to a reduction in the complement activation/inflammatory process. This work suggests that the evaluation of the composition of the different SLRPs in OA cartilage could be applied as a new tool for OA prognosis classification.


Disclosure: A. Farran, None; G. Valverde-Franco, None; L. Tio, None; B. Lussier, None; H. Fahmi, None; J. P. Pelletier, None; P. Bishop, None; J. Monfort, None; J. Martel-Pelletier, None.

To cite this abstract in AMA style:

Farran A, Valverde-Franco G, Tio L, Lussier B, Fahmi H, Pelletier JP, Bishop P, Monfort J, Martel-Pelletier J. In Vivo Effect of Opticin Deficiency in a Surgically Induced Mouse Model of Osteoarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/in-vivo-effect-of-opticin-deficiency-in-a-surgically-induced-mouse-model-of-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/in-vivo-effect-of-opticin-deficiency-in-a-surgically-induced-mouse-model-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology